Comparison of the efficacy of Bituvi/Bikonprenol tablets and Doveto

Biktarvy/Biktarvy is a fixed compound preparation that integrates the three ingredients of biktegravir sodium, emtricitabine and tenofovir alafenamide into one tablet, forming a complete triple regimen. It is designed to provide highly effective, broad-spectrum antiviral suppression to initial treatment patients while reducing the inconvenience of taking multiple pills per day. Dovato (Dovato) consists of dolutegravir and lamivudine. It is a two-drug regimen. Its clinical goal is to simplify treatment while reducing long-term drug exposure and potential side effects. Both reflect the trend of "monolithization and simplicity" in modern antiviral treatment, but there are differences in applicable groups and treatment strategies.

From the perspective of the efficacy of AIDS, the three-drug combination of Bituvitin has a wider coverage of viral suppression, is especially suitable for people who are new to treatment, and can achieve stable virological indicators in a relatively short period of time. Although Doveto contains fewer drug ingredients, it can maintain long-term virological suppression in stable populations or under specific conditions. The advantage is that it reduces drug interactions and possible long-term cumulative toxicity. Data show that both perform very well in terms of viral suppression rate, but Bitover is more commonly used in the initial stage, while Doveto is recommended for some patients as long-term maintenance treatment.

In terms of safety, Bituvet has been optimized and designed to have significantly less impact on kidneys and bone density than traditional regimens, which is particularly important for young patients or those who require long-term medication. Due to the smaller number of drugs, Doveto has a relatively lower risk of tolerability and drug interactions, making it especially suitable for patients with comorbidities or long-term use of multiple drugs.

In general, Bituvi is more suitable for treatment-naïve patients, emphasizing all-round coverage and powerful suppression, while Doveto works in the stable control phase, emphasizing safety and simplicity.

Reference materials:https://www.biktarvy.com/